The integrated stress response in cancer progression: a force for plasticity and resistance

During their quest for growth, adaptation, and survival, Cancer cells create a favorable environment through the manipulation of normal cellular mechanisms. They increase anabolic processes, including protein synthesis, to facilitate uncontrolled proliferation and deplete the tumor microenvironment of resources. As a dynamic adaptation to the self-imposed oncogenic stress, Cancer cells promptly hijack translational control to alter gene expression. Rewiring the cellular proteome shifts the phenotypic balance between growth and adaptation to promote therapeutic resistance and Cancer cell survival. The integrated stress response (ISR) is a key translational program activated by oncogenic stress that is utilized to fine-tune protein synthesis and adjust to environmental barriers. Here, we focus on the role of ISR signaling for driving Cancer progression. We highlight mechanisms of regulation for distinct mRNA translation downstream of the ISR, expand on oncogenic signaling utilizing the ISR in response to environmental stresses, and pinpoint the impact this has for Cancer cell plasticity during resistance to therapy. There is an ongoing need for innovative drug targets in Cancer treatment, and modulating ISR activity may provide a unique avenue for clinical benefit.

adaptation; cancer; drug resistance; mRNA translation; stress response.